Somnigroup International Inc (SGI) 10-Year Financial Performance & Capital Metrics

SGI • • Industrial / General

Consumer DefensiveHousehold ProductsHealth & Wellness ProductsNutritional Supplements

AboutSomni is a company specializing in sleep technology and wellness solutions, developing innovative products to enhance sleep quality. The company integrates science-backed methods, smart technology, and data-driven insights to improve sleep patterns and overall well-being.Show more

Revenue $4.93B +0.1%
EBITDA $799M +7.6%
Net Income $384M +4.4%
EPS (Diluted) 2.16 +3.8%
Gross Margin 44.21% +2.3%
EBITDA Margin 16.21% +7.5%
Operating Margin 12.86% +4.3%
Net Margin 7.79% +4.3%
ROE 85.24% -62.8%
ROIC 11.27% -15.7%
Debt/Equity 7.86 -19.7%
Interest Coverage 4.70 +0.6%

Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

✓Excellent 3Y average ROE of 212.3%
✓High quality earnings: Operating CF exceeds net income
✓Strong 5Y sales CAGR of 56.0%
✓Trading near 52-week high

✗Weaknesses

✗High debt to equity ratio of 7.9x
✗Expensive at 29.2x book value

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y22.85%

5Y56.05%

3Y0%

TTM39.29%

Profit (Net Income) CAGR

10Y-

5Y-

3Y-14.94%

TTM-19.08%

EPS CAGR

10Y-

5Y-

3Y-10.96%

TTM-30.14%

ROCE

10Y Avg5.95%

5Y Avg25.43%

3Y Avg17.47%

Latest14.64%

Peer Comparison

Nutritional Supplements

Name	Market Cap	Current Price	P/E Ratio	Revenue Growth 1Y	Net Margin	ROE	FCF Yield	Debt/Equity
SGISomnigroup International Inc	19.52B	92.99	43.05	0.11%	4.62%	10.53%	2.92%	7.86
KVUEKenvue Inc.	33.07B	17.26	31.96	0.07%	9.55%	13.48%	4.04%	0.90
MTEXMannatech, Incorporated	17.36M	9.13	6.92	-10.68%	-1.5%	-23.83%	11.32%	0.78
NUSNu Skin Enterprises, Inc.	552.83M	11.34	-3.84	-12.04%	7.02%	13.7%	12.69%	0.73

Profit & Loss

	Jun 2012	Jun 2013	Jun 2014	Jun 2015	Jun 2016	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Sales/Revenue+	752.99M	767.23M	529.95M	521.26M	532.93M	3.68B	4.93B	4.92B	4.93B	4.93B
Revenue Growth %	0.2%	0.02%	-0.31%	-0.02%	0.02%	5.9%	0.34%	-0%	0%	0%
Cost of Goods Sold+	559.17M	578.17M	391.54M	386.62M	388.38M	2.04B	2.77B	2.87B	2.8B	2.75B
COGS % of Revenue	0.74%	0.75%	0.74%	0.74%	0.73%	0.55%	0.56%	0.58%	0.57%	0.56%
Gross Profit+	193.82M	189.05M	138.41M	134.64M	144.54M	1.64B	2.16B	2.05B	2.13B	2.18B
Gross Margin %	0.26%	0.25%	0.26%	0.26%	0.27%	0.45%	0.44%	0.42%	0.43%	0.44%
Gross Profit Growth %	0.14%	-0.02%	-0.27%	-0.03%	0.07%	10.33%	0.32%	-0.05%	0.04%	0.02%
Operating Expenses+	215.26M	202.71M	193.25M	168.73M	150.08M	1.11B	1.25B	1.37B	1.52B	1.55B
OpEx % of Revenue	0.29%	0.26%	0.36%	0.32%	0.28%	0.3%	0.25%	0.28%	0.31%	0.31%
Selling, General & Admin	62.02M	54.32M	55.8M	53.86M	47.86M	1.12B	1.28B	1.39B	1.54B	1.56B
SG&A % of Revenue	0.08%	0.07%	0.11%	0.1%	0.09%	0.31%	0.26%	0.28%	0.31%	0.32%
Research & Development	62.36M	60.61M	63.53M	53.21M	50.7M	0	0	0	0	0
R&D % of Revenue	0.08%	0.08%	0.12%	0.1%	0.1%	-	-	-	-	-
Other Operating Expenses	90.88M	87.78M	73.93M	61.66M	51.52M	-16.4M	-30.6M	-21.1M	-23M	-18.9M
Operating Income+	-21.44M	-13.65M	-54.85M	-34.09M	-1.11M	532.1M	912.3M	680.6M	607.2M	634.2M
Operating Margin %	-0.03%	-0.02%	-0.1%	-0.07%	-0%	0.14%	0.19%	0.14%	0.12%	0.13%
Operating Income Growth %	-0.13%	0.36%	-3.02%	0.38%	0.97%	479.51%	0.71%	-0.25%	-0.11%	0.04%
EBITDA+	-6.87M	615K	-40.3M	-22.9M	9.95M	630.1M	1.03B	807.7M	742.5M	799.3M
EBITDA Margin %	-0.01%	0%	-0.08%	-0.04%	0.02%	0.17%	0.21%	0.16%	0.15%	0.16%
EBITDA Growth %	-4.77%	1.09%	-66.53%	0.43%	1.43%	62.33%	0.63%	-0.21%	-0.08%	0.08%
D&A (Non-Cash Add-back)	14.57M	14.27M	14.55M	11.19M	11.06M	98M	113.2M	127.1M	135.3M	165.1M
EBIT	-23.46M	-15.44M	-52.8M	-38.7M	-11.8M	529.4M	890.3M	680.2M	604M	639.1M
Net Interest Income+	0	0	0	0	0	-77M	-66.3M	-103M	-129.9M	-134.8M
Interest Income	0	0	0	0	0	0	0	0	0	0
Interest Expense	0	0	0	0	0	77M	66.3M	103M	129.9M	134.8M
Other Income/Expense	-2.02M	-1.79M	2.04M	-4.62M	-10.69M	-79.7M	-88.3M	-103.4M	-133.1M	-129.9M
Pretax Income+	-23.46M	-15.44M	-52.8M	-38.7M	-11.8M	452.4M	824M	577.2M	474.1M	504.3M
Pretax Margin %	-0.03%	-0.02%	-0.1%	-0.07%	-0.02%	0.12%	0.17%	0.12%	0.1%	0.1%
Income Tax+	1M	-12.62M	12K	440K	-626K	102.6M	198.3M	119M	103.4M	118.6M
Effective Tax Rate %	1.04%	0.18%	1%	1.01%	0.95%	0.77%	0.76%	0.79%	0.78%	0.76%
Net Income+	-24.46M	-2.82M	-52.81M	-39.15M	-11.18M	348.8M	624.5M	455.7M	368.1M	384.3M
Net Margin %	-0.03%	-0%	-0.1%	-0.08%	-0.02%	0.09%	0.13%	0.09%	0.07%	0.08%
Net Income Growth %	-0.15%	0.88%	-17.73%	0.26%	0.71%	32.2%	0.79%	-0.27%	-0.19%	0.04%
Net Income (Continuing)	-24.46M	-2.82M	-52.81M	-39.15M	-11.18M	349.8M	625.7M	458.2M	370.7M	385.7M
Discontinued Operations	0	0	0	0	0	0	-700K	-400K	0	0
Minority Interest	0	0	0	0	0	9.9M	9.2M	9.8M	10M	9.3M
EPS (Diluted)+	-0.76	-0.08	-1.49	-1.10	-0.31	1.64	3.06	2.53	2.08	2.16
EPS Growth %	-0.1%	0.9%	-17.79%	0.26%	0.72%	6.29%	0.87%	-0.17%	-0.18%	0.04%
EPS (Basic)	-0.76	-0.08	-1.49	-1.10	-0.31	1.68	3.17	2.61	2.14	2.21
Diluted Shares Outstanding	32.29M	35.55M	35.55M	35.55M	35.74M	212.3M	204.3M	180.3M	177.3M	178.2M
Basic Shares Outstanding	32.29M	35.55M	35.55M	35.55M	35.74M	207.9M	197M	174.9M	172.2M	173.6M
Dividend Payout Ratio	-	-	-	-	-	-	0.1%	0.15%	0.21%	0.24%

Balance Sheet

	Jun 2012	Jun 2013	Jun 2014	Jun 2015	Jun 2016	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Current Assets+	395.37M	332.62M	262.98M	300.01M	263.95M	968.4M	1.28B	1.2B	1.1B	1.07B
Cash & Short-Term Investments	104.85M	175.18M	109.3M	67.19M	92.95M	65M	300.7M	69.4M	74.9M	117.4M
Cash Only	104.85M	175.18M	109.3M	67.19M	92.95M	65M	300.7M	69.4M	74.9M	117.4M
Short-Term Investments	0	0	0	0	0	0	0	0	0	0
Accounts Receivable	98.29M	59.84M	72.08M	118.22M	85.83M	383.7M	419.5M	422.6M	431.4M	404.5M
Days Sales Outstanding	47.65	28.47	49.64	82.78	58.79	38.09	31.05	31.34	31.97	29.94
Inventory	123.39M	61.77M	47.35M	82.83M	55.91M	312.1M	463.9M	555M	483.1M	447M
Days Inventory Outstanding	80.54	39	44.14	78.2	52.54	55.88	61.08	70.54	63.05	59.31
Other Current Assets	68.83M	35.83M	34.26M	31.76M	29.26M	0	0	148.2M	113.8M	96.5M
Total Non-Current Assets+	101.52M	75.23M	101.96M	87.58M	92.18M	2.34B	3.05B	3.16B	3.45B	4.92B
Property, Plant & Equipment	27.4M	26.17M	34.58M	38.48M	40.53M	812.2M	1.06B	1.3B	1.51B	1.41B
Fixed Asset Turnover	27.48x	29.32x	15.32x	13.55x	13.15x	4.53x	4.63x	3.79x	3.25x	3.50x
Goodwill	0	0	0	0	0	766.3M	1.11B	1.06B	1.08B	1.07B
Intangible Assets	8.68M	4.64M	0	0	0	630.1M	750.9M	715.8M	714.8M	700.5M
Long-Term Investments	7.3M	7.8M	8.2M	7M	7.1M	0	0	0	0	1.59B
Other Non-Current Assets	42.7M	30.85M	42.51M	42.05M	43.06M	118.1M	111.8M	77.3M	122.2M	130.3M
Total Assets+	496.88M	407.85M	364.94M	387.58M	356.13M	3.31B	4.32B	4.36B	4.55B	5.98B
Asset Turnover	1.52x	1.88x	1.45x	1.34x	1.50x	1.11x	1.14x	1.13x	1.08x	0.82x
Asset Growth %	0.1%	-0.18%	-0.11%	0.06%	-0.08%	8.29%	0.31%	0.01%	0.04%	0.31%
Total Current Liabilities+	282.4M	201.76M	205.51M	199.22M	167.38M	974.8M	1.05B	981.2M	908.2M	960.3M
Accounts Payable	85.8M	191.2M	226.4M	266.3M	235M	324.1M	432M	359.8M	311.3M	360.5M
Days Payables Outstanding	56.01	120.7	211.05	251.41	220.85	58.03	56.88	45.73	40.63	47.83
Short-Term Debt	48.59M	35.36M	53.66M	3.1M	3.78M	43.9M	53M	70.4M	44.9M	69.5M
Deferred Revenue (Current)	1000K	1000K	1000K	1000K	1000K	0	1000K	1000K	1000K	1000K
Other Current Liabilities	39.45M	28.5M	20.05M	50.98M	43.45M	0	205.8M	189.2M	193.7M	177.7M
Current Ratio	1.40x	1.65x	1.28x	1.51x	1.58x	0.99x	1.21x	1.22x	1.21x	1.11x
Quick Ratio	0.96x	1.34x	1.05x	1.09x	1.24x	0.67x	0.77x	0.65x	0.68x	0.64x
Cash Conversion Cycle	72.18	-53.24	-117.27	-90.43	-109.52	35.94	35.25	56.16	54.39	41.42
Total Non-Current Liabilities+	92.1M	64.3M	70.66M	127.89M	119.87M	1.82B	2.98B	3.39B	3.31B	4.45B
Long-Term Debt	0	0	6.31M	67.81M	57.91M	1.32B	2.28B	2.74B	2.53B	3.74B
Capital Lease Obligations	0	0	0	0	0	275.1M	427M	453.5M	574.8M	532.1M
Deferred Tax Liabilities	20.57M	10.15M	10.11M	8.42M	7.53M	90.4M	129.2M	114M	127.9M	108.3M
Other Non-Current Liabilities	6.81M	3.79M	8.81M	7.87M	7.82M	131.8M	140.3M	83.5M	82.6M	71M
Total Liabilities	385.99M	277.6M	282.79M	334.21M	300.94M	2.8B	4.03B	4.37B	4.22B	5.41B
Total Debt+	48.59M	35.36M	59.97M	70.91M	61.68M	1.7B	2.86B	3.37B	3.27B	4.47B
Net Debt	-56.26M	-139.82M	-49.33M	3.72M	-31.26M	1.64B	2.56B	3.3B	3.19B	4.35B
Debt / Equity	0.44x	0.27x	0.73x	1.33x	1.12x	3.32x	9.70x	-	9.80x	7.86x
Debt / EBITDA	-	57.50x	-	-	6.20x	2.70x	2.79x	4.17x	4.40x	5.59x
Net Debt / EBITDA	-	-227.34x	-	-	-3.14x	2.60x	2.50x	4.09x	4.30x	5.44x
Interest Coverage	-	-	-	-	-	6.91x	13.76x	6.61x	4.67x	4.70x
Total Equity+	110.89M	130.25M	82.15M	53.38M	55.19M	513.5M	295M	-12.3M	333.4M	568.3M
Equity Growth %	-0.1%	0.17%	-0.37%	-0.35%	0.03%	8.3%	-0.43%	-1.04%	28.11%	0.7%
Book Value per Share	3.43	3.66	2.31	1.50	1.54	2.42	1.44	-0.07	1.88	3.19
Total Shareholders' Equity	110.89M	130.25M	82.15M	53.38M	55.19M	503.6M	285.8M	-22.1M	323.4M	559M
Common Stock	33K	35K	36K	37K	39K	2.8M	2.8M	2.8M	2.8M	2.8M
Retained Earnings	-367.21M	-370.03M	-422.84M	-461.99M	-473.17M	2.05B	2.6B	2.99B	3.28B	3.57B
Treasury Stock	0	0	0	0	0	-2.1B	-2.84B	-3.43B	-3.38B	-3.33B
Accumulated OCI	-1.48M	-2.15M	-3.89M	-5.27M	-6.24M	-65.5M	-99.2M	-176.9M	-136.7M	-186.8M
Minority Interest	0	0	0	0	0	9.9M	9.2M	9.8M	10M	9.3M

Cash Flow

	Jun 2012	Jun 2013	Jun 2014	Jun 2015	Jun 2016	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Cash from Operations+	189.9M	98.5M	225.2M	234.2M	165.5M	654.7M	723.1M	378.8M	570.3M	666.5M
Operating CF Margin %	0.25%	0.13%	0.42%	0.45%	0.31%	0.18%	0.15%	0.08%	0.12%	0.14%
Operating CF Growth %	-0.24%	-0.48%	1.29%	0.04%	-0.29%	2.96%	0.1%	-0.48%	0.51%	0.17%
Net Income	106.8M	78.9M	110M	65.7M	197.3M	348.8M	625.2M	456.1M	370.7M	385.7M
Depreciation & Amortization	36.3M	74.6M	76.3M	71.4M	72.4M	98M	113.2M	127.1M	135.3M	165.1M
Stock-Based Compensation	5.7M	16.9M	13.4M	22.5M	16.2M	0	0	0	47.7M	36.4M
Deferred Taxes	38.4M	-49.1M	-27.2M	-21.3M	-31.1M	-8.6M	11.1M	-10.5M	8.3M	-19.2M
Other Non-Cash Items	6M	16.1M	45.1M	37.7M	54.5M	147.5M	64.2M	67.9M	10M	33.9M
Working Capital Changes	-3.3M	-38.9M	7.6M	58.2M	-143.8M	69M	-90.6M	-261.8M	-1.7M	64.6M
Change in Receivables	5.3M	-30.1M	-58.8M	-38.4M	21.5M	-55.7M	-40.4M	-14.8M	-11.5M	-7.3M
Change in Inventory	100K	-34.5M	-34M	10.7M	700K	-42.5M	-106.4M	-101.9M	75.8M	26.8M
Change in Payables	14.3M	28.1M	47.8M	52.8M	-48.3M	63M	50.5M	-59.5M	-46.9M	58.3M
Cash from Investing+	-55M	-1.21B	-10.4M	-59.7M	-62.4M	-146.3M	-555.7M	-315.6M	-187.8M	-96.7M
Capital Expenditures	-50.5M	-40M	-47.5M	-65.9M	-61.9M	-111.3M	-123.3M	-306.5M	-185.4M	-97.3M
CapEx % of Revenue	0.07%	0.05%	0.09%	0.13%	0.12%	0.03%	0.03%	0.06%	0.04%	0.02%
Acquisitions	-	-	-	-	-	-	-	-	-	-
Investments	-	-	-	-	-	-	-	-	-	-
Other Investing	0	-100K	2.1M	-1M	-500K	6.2M	400K	-9.1M	-2.4M	600K
Cash from Financing+	-70.8M	1.01B	-238.1M	-90.7M	-185.1M	-522.6M	76.5M	-279.1M	-384.3M	1.08B
Debt Issued (Net)	-	-	-	-	-	-	-	-	-	-
Equity Issued (Net)	-	-	-	-	-	-	-	-	-	-
Dividends Paid	0	0	0	0	0	0	-63.1M	-70.5M	-77.7M	-92.7M
Share Repurchases	-	-	-	-	-	-	-	-	-	-
Other Financing	16.8M	-38.9M	3.5M	30.4M	7.9M	-11.9M	-13.4M	0	-3.6M	-13.2M
Net Change in Cash	-	-	-	-	-	-	-	-	-	-
Free Cash Flow+	139.4M	58.5M	177.7M	168.3M	103.6M	543.4M	599.8M	72.3M	384.9M	569.2M
FCF Margin %	0.19%	0.08%	0.34%	0.32%	0.19%	0.15%	0.12%	0.01%	0.08%	0.12%
FCF Growth %	-0.36%	-0.58%	2.04%	-0.05%	-0.38%	4.25%	0.1%	-0.88%	4.32%	0.48%
FCF per Share	4.32	1.65	5.00	4.73	2.90	2.56	2.94	0.40	2.17	3.19
FCF Conversion (FCF/Net Income)	-7.76x	-34.93x	-4.26x	-5.98x	-14.81x	1.88x	1.16x	0.83x	1.55x	1.73x
Interest Paid	37.1M	92.1M	73.5M	66.5M	75.4M	0	0	0	144.6M	157.7M
Taxes Paid	80.1M	96.4M	56.3M	94.9M	81.3M	0	0	0	133M	134M

Key Ratios

Metric	2012	2013	2014	2015	2016	2020	2021	2022	2023	2024
Return on Equity (ROE)	-20.89%	-2.34%	-49.73%	-57.77%	-20.59%	122.67%	154.48%	322.39%	229.27%	85.24%
Return on Invested Capital (ROIC)	-84.54%	-45.45%	-353.64%	-56.86%	-2.06%	36.69%	27.34%	16.62%	13.37%	11.27%
Gross Margin	25.74%	24.64%	26.12%	25.83%	27.12%	44.56%	43.78%	41.65%	43.22%	44.21%
Net Margin	-3.25%	-0.37%	-9.97%	-7.51%	-2.1%	9.49%	12.67%	9.26%	7.47%	7.79%
Debt / Equity	0.44x	0.27x	0.73x	1.33x	1.12x	3.32x	9.70x	-	9.80x	7.86x
Interest Coverage	-	-	-	-	-	6.91x	13.76x	6.61x	4.67x	4.70x
FCF Conversion	-7.76x	-34.93x	-4.26x	-5.98x	-14.81x	1.88x	1.16x	0.83x	1.55x	1.73x
Revenue Growth	19.6%	1.89%	-30.93%	-1.64%	2.24%	589.94%	34.1%	-0.19%	0.09%	0.11%

Frequently Asked Questions

Valuation & Price

Somnigroup International Inc (SGI) has a price-to-earnings (P/E) ratio of 43.1x. This suggests investors expect higher future growth.

Growth & Financials

Somnigroup International Inc (SGI) reported $6.82B in revenue for fiscal year 2024. This represents a 1791% increase from $360.4M in 2006.

Somnigroup International Inc (SGI) grew revenue by 0.1% over the past year. Growth has been modest.

Yes, Somnigroup International Inc (SGI) is profitable, generating $315.2M in net income for fiscal year 2024 (7.8% net margin).

Dividend & Returns

Yes, Somnigroup International Inc (SGI) pays a dividend with a yield of 0.56%. This makes it attractive for income-focused investors.

Somnigroup International Inc (SGI) has a return on equity (ROE) of 85.2%. This is excellent, indicating efficient use of shareholder capital.

Somnigroup International Inc (SGI) generated $700.3M in free cash flow for fiscal year 2024. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.

US Stock Screener

...

Somnigroup International Inc (SGI) 10-Year Financial Performance & Capital Metrics

SGI • • Industrial / General

Consumer DefensiveHousehold ProductsHealth & Wellness ProductsNutritional Supplements

Revenue $4.93B +0.1%
EBITDA $799M +7.6%
Net Income $384M +4.4%
EPS (Diluted) 2.16 +3.8%
Gross Margin 44.21% +2.3%
EBITDA Margin 16.21% +7.5%
Operating Margin 12.86% +4.3%
Net Margin 7.79% +4.3%
ROE 85.24% -62.8%
ROIC 11.27% -15.7%
Debt/Equity 7.86 -19.7%
Interest Coverage 4.70 +0.6%

Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

✓Excellent 3Y average ROE of 212.3%
✓High quality earnings: Operating CF exceeds net income
✓Strong 5Y sales CAGR of 56.0%
✓Trading near 52-week high

✗Weaknesses

✗High debt to equity ratio of 7.9x
✗Expensive at 29.2x book value

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y22.85%

5Y56.05%

3Y0%

TTM39.29%

Profit (Net Income) CAGR

10Y-

5Y-

3Y-14.94%

TTM-19.08%

EPS CAGR

10Y-

5Y-

3Y-10.96%

TTM-30.14%

ROCE

10Y Avg5.95%

5Y Avg25.43%

3Y Avg17.47%

Latest14.64%

Peer Comparison

Nutritional Supplements

Name	Market Cap	Current Price	P/E Ratio	Revenue Growth 1Y	Net Margin	ROE	FCF Yield	Debt/Equity
SGISomnigroup International Inc	19.52B	92.99	43.05	0.11%	4.62%	10.53%	2.92%	7.86
KVUEKenvue Inc.	33.07B	17.26	31.96	0.07%	9.55%	13.48%	4.04%	0.90
MTEXMannatech, Incorporated	17.36M	9.13	6.92	-10.68%	-1.5%	-23.83%	11.32%	0.78
NUSNu Skin Enterprises, Inc.	552.83M	11.34	-3.84	-12.04%	7.02%	13.7%	12.69%	0.73

Profit & Loss

	Jun 2012	Jun 2013	Jun 2014	Jun 2015	Jun 2016	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Sales/Revenue+	752.99M	767.23M	529.95M	521.26M	532.93M	3.68B	4.93B	4.92B	4.93B	4.93B
Revenue Growth %	0.2%	0.02%	-0.31%	-0.02%	0.02%	5.9%	0.34%	-0%	0%	0%
Cost of Goods Sold+	559.17M	578.17M	391.54M	386.62M	388.38M	2.04B	2.77B	2.87B	2.8B	2.75B
COGS % of Revenue	0.74%	0.75%	0.74%	0.74%	0.73%	0.55%	0.56%	0.58%	0.57%	0.56%
Gross Profit+	193.82M	189.05M	138.41M	134.64M	144.54M	1.64B	2.16B	2.05B	2.13B	2.18B
Gross Margin %	0.26%	0.25%	0.26%	0.26%	0.27%	0.45%	0.44%	0.42%	0.43%	0.44%
Gross Profit Growth %	0.14%	-0.02%	-0.27%	-0.03%	0.07%	10.33%	0.32%	-0.05%	0.04%	0.02%
Operating Expenses+	215.26M	202.71M	193.25M	168.73M	150.08M	1.11B	1.25B	1.37B	1.52B	1.55B
OpEx % of Revenue	0.29%	0.26%	0.36%	0.32%	0.28%	0.3%	0.25%	0.28%	0.31%	0.31%
Selling, General & Admin	62.02M	54.32M	55.8M	53.86M	47.86M	1.12B	1.28B	1.39B	1.54B	1.56B
SG&A % of Revenue	0.08%	0.07%	0.11%	0.1%	0.09%	0.31%	0.26%	0.28%	0.31%	0.32%
Research & Development	62.36M	60.61M	63.53M	53.21M	50.7M	0	0	0	0	0
R&D % of Revenue	0.08%	0.08%	0.12%	0.1%	0.1%	-	-	-	-	-
Other Operating Expenses	90.88M	87.78M	73.93M	61.66M	51.52M	-16.4M	-30.6M	-21.1M	-23M	-18.9M
Operating Income+	-21.44M	-13.65M	-54.85M	-34.09M	-1.11M	532.1M	912.3M	680.6M	607.2M	634.2M
Operating Margin %	-0.03%	-0.02%	-0.1%	-0.07%	-0%	0.14%	0.19%	0.14%	0.12%	0.13%
Operating Income Growth %	-0.13%	0.36%	-3.02%	0.38%	0.97%	479.51%	0.71%	-0.25%	-0.11%	0.04%
EBITDA+	-6.87M	615K	-40.3M	-22.9M	9.95M	630.1M	1.03B	807.7M	742.5M	799.3M
EBITDA Margin %	-0.01%	0%	-0.08%	-0.04%	0.02%	0.17%	0.21%	0.16%	0.15%	0.16%
EBITDA Growth %	-4.77%	1.09%	-66.53%	0.43%	1.43%	62.33%	0.63%	-0.21%	-0.08%	0.08%
D&A (Non-Cash Add-back)	14.57M	14.27M	14.55M	11.19M	11.06M	98M	113.2M	127.1M	135.3M	165.1M
EBIT	-23.46M	-15.44M	-52.8M	-38.7M	-11.8M	529.4M	890.3M	680.2M	604M	639.1M
Net Interest Income+	0	0	0	0	0	-77M	-66.3M	-103M	-129.9M	-134.8M
Interest Income	0	0	0	0	0	0	0	0	0	0
Interest Expense	0	0	0	0	0	77M	66.3M	103M	129.9M	134.8M
Other Income/Expense	-2.02M	-1.79M	2.04M	-4.62M	-10.69M	-79.7M	-88.3M	-103.4M	-133.1M	-129.9M
Pretax Income+	-23.46M	-15.44M	-52.8M	-38.7M	-11.8M	452.4M	824M	577.2M	474.1M	504.3M
Pretax Margin %	-0.03%	-0.02%	-0.1%	-0.07%	-0.02%	0.12%	0.17%	0.12%	0.1%	0.1%
Income Tax+	1M	-12.62M	12K	440K	-626K	102.6M	198.3M	119M	103.4M	118.6M
Effective Tax Rate %	1.04%	0.18%	1%	1.01%	0.95%	0.77%	0.76%	0.79%	0.78%	0.76%
Net Income+	-24.46M	-2.82M	-52.81M	-39.15M	-11.18M	348.8M	624.5M	455.7M	368.1M	384.3M
Net Margin %	-0.03%	-0%	-0.1%	-0.08%	-0.02%	0.09%	0.13%	0.09%	0.07%	0.08%
Net Income Growth %	-0.15%	0.88%	-17.73%	0.26%	0.71%	32.2%	0.79%	-0.27%	-0.19%	0.04%
Net Income (Continuing)	-24.46M	-2.82M	-52.81M	-39.15M	-11.18M	349.8M	625.7M	458.2M	370.7M	385.7M
Discontinued Operations	0	0	0	0	0	0	-700K	-400K	0	0
Minority Interest	0	0	0	0	0	9.9M	9.2M	9.8M	10M	9.3M
EPS (Diluted)+	-0.76	-0.08	-1.49	-1.10	-0.31	1.64	3.06	2.53	2.08	2.16
EPS Growth %	-0.1%	0.9%	-17.79%	0.26%	0.72%	6.29%	0.87%	-0.17%	-0.18%	0.04%
EPS (Basic)	-0.76	-0.08	-1.49	-1.10	-0.31	1.68	3.17	2.61	2.14	2.21
Diluted Shares Outstanding	32.29M	35.55M	35.55M	35.55M	35.74M	212.3M	204.3M	180.3M	177.3M	178.2M
Basic Shares Outstanding	32.29M	35.55M	35.55M	35.55M	35.74M	207.9M	197M	174.9M	172.2M	173.6M
Dividend Payout Ratio	-	-	-	-	-	-	0.1%	0.15%	0.21%	0.24%

Balance Sheet

	Jun 2012	Jun 2013	Jun 2014	Jun 2015	Jun 2016	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Current Assets+	395.37M	332.62M	262.98M	300.01M	263.95M	968.4M	1.28B	1.2B	1.1B	1.07B
Cash & Short-Term Investments	104.85M	175.18M	109.3M	67.19M	92.95M	65M	300.7M	69.4M	74.9M	117.4M
Cash Only	104.85M	175.18M	109.3M	67.19M	92.95M	65M	300.7M	69.4M	74.9M	117.4M
Short-Term Investments	0	0	0	0	0	0	0	0	0	0
Accounts Receivable	98.29M	59.84M	72.08M	118.22M	85.83M	383.7M	419.5M	422.6M	431.4M	404.5M
Days Sales Outstanding	47.65	28.47	49.64	82.78	58.79	38.09	31.05	31.34	31.97	29.94
Inventory	123.39M	61.77M	47.35M	82.83M	55.91M	312.1M	463.9M	555M	483.1M	447M
Days Inventory Outstanding	80.54	39	44.14	78.2	52.54	55.88	61.08	70.54	63.05	59.31
Other Current Assets	68.83M	35.83M	34.26M	31.76M	29.26M	0	0	148.2M	113.8M	96.5M
Total Non-Current Assets+	101.52M	75.23M	101.96M	87.58M	92.18M	2.34B	3.05B	3.16B	3.45B	4.92B
Property, Plant & Equipment	27.4M	26.17M	34.58M	38.48M	40.53M	812.2M	1.06B	1.3B	1.51B	1.41B
Fixed Asset Turnover	27.48x	29.32x	15.32x	13.55x	13.15x	4.53x	4.63x	3.79x	3.25x	3.50x
Goodwill	0	0	0	0	0	766.3M	1.11B	1.06B	1.08B	1.07B
Intangible Assets	8.68M	4.64M	0	0	0	630.1M	750.9M	715.8M	714.8M	700.5M
Long-Term Investments	7.3M	7.8M	8.2M	7M	7.1M	0	0	0	0	1.59B
Other Non-Current Assets	42.7M	30.85M	42.51M	42.05M	43.06M	118.1M	111.8M	77.3M	122.2M	130.3M
Total Assets+	496.88M	407.85M	364.94M	387.58M	356.13M	3.31B	4.32B	4.36B	4.55B	5.98B
Asset Turnover	1.52x	1.88x	1.45x	1.34x	1.50x	1.11x	1.14x	1.13x	1.08x	0.82x
Asset Growth %	0.1%	-0.18%	-0.11%	0.06%	-0.08%	8.29%	0.31%	0.01%	0.04%	0.31%
Total Current Liabilities+	282.4M	201.76M	205.51M	199.22M	167.38M	974.8M	1.05B	981.2M	908.2M	960.3M
Accounts Payable	85.8M	191.2M	226.4M	266.3M	235M	324.1M	432M	359.8M	311.3M	360.5M
Days Payables Outstanding	56.01	120.7	211.05	251.41	220.85	58.03	56.88	45.73	40.63	47.83
Short-Term Debt	48.59M	35.36M	53.66M	3.1M	3.78M	43.9M	53M	70.4M	44.9M	69.5M
Deferred Revenue (Current)	1000K	1000K	1000K	1000K	1000K	0	1000K	1000K	1000K	1000K
Other Current Liabilities	39.45M	28.5M	20.05M	50.98M	43.45M	0	205.8M	189.2M	193.7M	177.7M
Current Ratio	1.40x	1.65x	1.28x	1.51x	1.58x	0.99x	1.21x	1.22x	1.21x	1.11x
Quick Ratio	0.96x	1.34x	1.05x	1.09x	1.24x	0.67x	0.77x	0.65x	0.68x	0.64x
Cash Conversion Cycle	72.18	-53.24	-117.27	-90.43	-109.52	35.94	35.25	56.16	54.39	41.42
Total Non-Current Liabilities+	92.1M	64.3M	70.66M	127.89M	119.87M	1.82B	2.98B	3.39B	3.31B	4.45B
Long-Term Debt	0	0	6.31M	67.81M	57.91M	1.32B	2.28B	2.74B	2.53B	3.74B
Capital Lease Obligations	0	0	0	0	0	275.1M	427M	453.5M	574.8M	532.1M
Deferred Tax Liabilities	20.57M	10.15M	10.11M	8.42M	7.53M	90.4M	129.2M	114M	127.9M	108.3M
Other Non-Current Liabilities	6.81M	3.79M	8.81M	7.87M	7.82M	131.8M	140.3M	83.5M	82.6M	71M
Total Liabilities	385.99M	277.6M	282.79M	334.21M	300.94M	2.8B	4.03B	4.37B	4.22B	5.41B
Total Debt+	48.59M	35.36M	59.97M	70.91M	61.68M	1.7B	2.86B	3.37B	3.27B	4.47B
Net Debt	-56.26M	-139.82M	-49.33M	3.72M	-31.26M	1.64B	2.56B	3.3B	3.19B	4.35B
Debt / Equity	0.44x	0.27x	0.73x	1.33x	1.12x	3.32x	9.70x	-	9.80x	7.86x
Debt / EBITDA	-	57.50x	-	-	6.20x	2.70x	2.79x	4.17x	4.40x	5.59x
Net Debt / EBITDA	-	-227.34x	-	-	-3.14x	2.60x	2.50x	4.09x	4.30x	5.44x
Interest Coverage	-	-	-	-	-	6.91x	13.76x	6.61x	4.67x	4.70x
Total Equity+	110.89M	130.25M	82.15M	53.38M	55.19M	513.5M	295M	-12.3M	333.4M	568.3M
Equity Growth %	-0.1%	0.17%	-0.37%	-0.35%	0.03%	8.3%	-0.43%	-1.04%	28.11%	0.7%
Book Value per Share	3.43	3.66	2.31	1.50	1.54	2.42	1.44	-0.07	1.88	3.19
Total Shareholders' Equity	110.89M	130.25M	82.15M	53.38M	55.19M	503.6M	285.8M	-22.1M	323.4M	559M
Common Stock	33K	35K	36K	37K	39K	2.8M	2.8M	2.8M	2.8M	2.8M
Retained Earnings	-367.21M	-370.03M	-422.84M	-461.99M	-473.17M	2.05B	2.6B	2.99B	3.28B	3.57B
Treasury Stock	0	0	0	0	0	-2.1B	-2.84B	-3.43B	-3.38B	-3.33B
Accumulated OCI	-1.48M	-2.15M	-3.89M	-5.27M	-6.24M	-65.5M	-99.2M	-176.9M	-136.7M	-186.8M
Minority Interest	0	0	0	0	0	9.9M	9.2M	9.8M	10M	9.3M

Cash Flow

	Jun 2012	Jun 2013	Jun 2014	Jun 2015	Jun 2016	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Cash from Operations+	189.9M	98.5M	225.2M	234.2M	165.5M	654.7M	723.1M	378.8M	570.3M	666.5M
Operating CF Margin %	0.25%	0.13%	0.42%	0.45%	0.31%	0.18%	0.15%	0.08%	0.12%	0.14%
Operating CF Growth %	-0.24%	-0.48%	1.29%	0.04%	-0.29%	2.96%	0.1%	-0.48%	0.51%	0.17%
Net Income	106.8M	78.9M	110M	65.7M	197.3M	348.8M	625.2M	456.1M	370.7M	385.7M
Depreciation & Amortization	36.3M	74.6M	76.3M	71.4M	72.4M	98M	113.2M	127.1M	135.3M	165.1M
Stock-Based Compensation	5.7M	16.9M	13.4M	22.5M	16.2M	0	0	0	47.7M	36.4M
Deferred Taxes	38.4M	-49.1M	-27.2M	-21.3M	-31.1M	-8.6M	11.1M	-10.5M	8.3M	-19.2M
Other Non-Cash Items	6M	16.1M	45.1M	37.7M	54.5M	147.5M	64.2M	67.9M	10M	33.9M
Working Capital Changes	-3.3M	-38.9M	7.6M	58.2M	-143.8M	69M	-90.6M	-261.8M	-1.7M	64.6M
Change in Receivables	5.3M	-30.1M	-58.8M	-38.4M	21.5M	-55.7M	-40.4M	-14.8M	-11.5M	-7.3M
Change in Inventory	100K	-34.5M	-34M	10.7M	700K	-42.5M	-106.4M	-101.9M	75.8M	26.8M
Change in Payables	14.3M	28.1M	47.8M	52.8M	-48.3M	63M	50.5M	-59.5M	-46.9M	58.3M
Cash from Investing+	-55M	-1.21B	-10.4M	-59.7M	-62.4M	-146.3M	-555.7M	-315.6M	-187.8M	-96.7M
Capital Expenditures	-50.5M	-40M	-47.5M	-65.9M	-61.9M	-111.3M	-123.3M	-306.5M	-185.4M	-97.3M
CapEx % of Revenue	0.07%	0.05%	0.09%	0.13%	0.12%	0.03%	0.03%	0.06%	0.04%	0.02%
Acquisitions	-	-	-	-	-	-	-	-	-	-
Investments	-	-	-	-	-	-	-	-	-	-
Other Investing	0	-100K	2.1M	-1M	-500K	6.2M	400K	-9.1M	-2.4M	600K
Cash from Financing+	-70.8M	1.01B	-238.1M	-90.7M	-185.1M	-522.6M	76.5M	-279.1M	-384.3M	1.08B
Debt Issued (Net)	-	-	-	-	-	-	-	-	-	-
Equity Issued (Net)	-	-	-	-	-	-	-	-	-	-
Dividends Paid	0	0	0	0	0	0	-63.1M	-70.5M	-77.7M	-92.7M
Share Repurchases	-	-	-	-	-	-	-	-	-	-
Other Financing	16.8M	-38.9M	3.5M	30.4M	7.9M	-11.9M	-13.4M	0	-3.6M	-13.2M
Net Change in Cash	-	-	-	-	-	-	-	-	-	-
Free Cash Flow+	139.4M	58.5M	177.7M	168.3M	103.6M	543.4M	599.8M	72.3M	384.9M	569.2M
FCF Margin %	0.19%	0.08%	0.34%	0.32%	0.19%	0.15%	0.12%	0.01%	0.08%	0.12%
FCF Growth %	-0.36%	-0.58%	2.04%	-0.05%	-0.38%	4.25%	0.1%	-0.88%	4.32%	0.48%
FCF per Share	4.32	1.65	5.00	4.73	2.90	2.56	2.94	0.40	2.17	3.19
FCF Conversion (FCF/Net Income)	-7.76x	-34.93x	-4.26x	-5.98x	-14.81x	1.88x	1.16x	0.83x	1.55x	1.73x
Interest Paid	37.1M	92.1M	73.5M	66.5M	75.4M	0	0	0	144.6M	157.7M
Taxes Paid	80.1M	96.4M	56.3M	94.9M	81.3M	0	0	0	133M	134M

Key Ratios

Metric	2012	2013	2014	2015	2016	2020	2021	2022	2023	2024
Return on Equity (ROE)	-20.89%	-2.34%	-49.73%	-57.77%	-20.59%	122.67%	154.48%	322.39%	229.27%	85.24%
Return on Invested Capital (ROIC)	-84.54%	-45.45%	-353.64%	-56.86%	-2.06%	36.69%	27.34%	16.62%	13.37%	11.27%
Gross Margin	25.74%	24.64%	26.12%	25.83%	27.12%	44.56%	43.78%	41.65%	43.22%	44.21%
Net Margin	-3.25%	-0.37%	-9.97%	-7.51%	-2.1%	9.49%	12.67%	9.26%	7.47%	7.79%
Debt / Equity	0.44x	0.27x	0.73x	1.33x	1.12x	3.32x	9.70x	-	9.80x	7.86x
Interest Coverage	-	-	-	-	-	6.91x	13.76x	6.61x	4.67x	4.70x
FCF Conversion	-7.76x	-34.93x	-4.26x	-5.98x	-14.81x	1.88x	1.16x	0.83x	1.55x	1.73x
Revenue Growth	19.6%	1.89%	-30.93%	-1.64%	2.24%	589.94%	34.1%	-0.19%	0.09%	0.11%

Frequently Asked Questions

Valuation & Price

Somnigroup International Inc (SGI) has a price-to-earnings (P/E) ratio of 43.1x. This suggests investors expect higher future growth.

Growth & Financials

Somnigroup International Inc (SGI) reported $6.82B in revenue for fiscal year 2024. This represents a 1791% increase from $360.4M in 2006.

Somnigroup International Inc (SGI) grew revenue by 0.1% over the past year. Growth has been modest.

Yes, Somnigroup International Inc (SGI) is profitable, generating $315.2M in net income for fiscal year 2024 (7.8% net margin).

Dividend & Returns

Yes, Somnigroup International Inc (SGI) pays a dividend with a yield of 0.56%. This makes it attractive for income-focused investors.

Somnigroup International Inc (SGI) has a return on equity (ROE) of 85.2%. This is excellent, indicating efficient use of shareholder capital.

Somnigroup International Inc (SGI) generated $700.3M in free cash flow for fiscal year 2024. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.